AHA today urged the Antitrust Division of the Department of Justice to investigate thoroughly Centene's proposed acquisition of WellCare “because it threatens to reduce competition in delivery of Medicaid managed care and Medicare Advantage services to tens of millions of consumers across broad swaths of the country.” The letter notes, “There is no service more important to American consumers than health care, and vigorous competition among health insurance companies is necessary to ensure that consumers receive high quality at affordable rates. The facts show that the WellCare-Centene transaction is likely to significantly reduce competition and will therefore harm the most vulnerable Americans. DOJ should vigorously review this transaction's effects on current and future competition and take all appropriate measures to protect U.S. consumers.”

Related News Articles

Headline
AHA presents variety of awards recognizing leaders across the health care fieldDuring its Annual Membership Meeting today in Washington, D.C., the AHA honored…
Headline
The Department of Justice March 27 announced it is launching an Anticompetitive Regulations Task Force to advocate for “the elimination of anticompetitive…
Headline
Health delivery organizations are encouraged to apply by 1 p.m. ET May 6 for the AHA’s 2026 Foster G. McGaw Prize, honoring organizations that demonstrate…
Headline
Hospitals and health systems are urged to nominate candidates as soon as possible for the AHA Next Generation Leaders Fellowship so they can apply by the March…
Headline
The Hospital Capacity Management Consortium, a professional membership group for hospital capacity management leaders, is now part of the AHA. The HCMC was…
Headline
Ian Morrison, a highly regarded author, consultant and futurist, died last week. He specialized in long-term forecasting and planning with a particular…